{"id":"W3025530165","doi":"10.1007/s13555-020-00383-x","title":"Ixekizumab and Ustekinumab Efficacy in Nail Psoriasis in Patients with Moderate-to-Severe Psoriasis: 52-Week Results from a Phase 3, Head-to-Head Study (IXORA-S)","year":2020,"lang":"en","type":"article","venue":"Dermatology and Therapy","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":39,"is_retracted":false,"has_abstract":true,"ca_institutions":"Probity Medical Research","funders":"Eli Lilly and Company","keywords":"Medicine; Psoriasis; Ixekizumab; Dermatology; Nail (fastener); Psoriasis Area and Severity Index; Ustekinumab; Plaque psoriasis; Internal medicine; Secukinumab; Psoriatic arthritis; Disease; Adalimumab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001426663,0.0004902722,0.0009539899,0.0002408777,0.0002017647,0.00003706581,0.0002282444,0.0003776723,0.00005095946],"category_scores_gemma":[0.00006933912,0.000401257,0.00005193504,0.0004993947,0.0001076869,0.0001536601,0.00008888646,0.0003339264,0.00009478485],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003414817,"about_ca_system_score_gemma":0.00005706621,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005412949,"about_ca_topic_score_gemma":0.0009266693,"domain_scores_codex":[0.9970198,0.0007044139,0.0006305779,0.0009986907,0.00007857729,0.0005679326],"domain_scores_gemma":[0.9989559,0.0003326779,0.0001341402,0.0003703113,0.00006444685,0.0001424921],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.2160782,0.01219736,0.3807704,0.00002534465,0.00159228,0.0005493129,0.05348099,0.00008504284,0.0008068415,0.00004547267,0.0006544678,0.3337143],"study_design_scores_gemma":[0.2287011,0.006893374,0.7541606,0.0001039751,0.0001597865,0.00006110446,0.001795028,0.00003454591,0.002926376,0.00008453122,0.004172469,0.0009070975],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9943179,0.001893297,0.0000160188,0.001434771,0.0002622278,0.001594116,0.0003584273,0.00007203913,0.00005113943],"genre_scores_gemma":[0.9978261,0.0002239638,0.0001030528,0.001256857,0.00003079995,0.0001603553,0.0003361653,0.00003923062,0.00002348895],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3733903,"threshold_uncertainty_score":0.999844,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02972612552435288,"score_gpt":0.266550465056885,"score_spread":0.2368243395325321,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}